<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN Xcelerate Taxonomy Schema - https://www.dfinsolutions.com/ -->
<!-- Version: 6.23.6 -->
<!-- Round: 4 -->
<!-- Creation date: 2019-08-28T16:13:27Z -->
<!-- Copyright (c) 2019 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<schema xmlns="http://www.w3.org/2001/XMLSchema"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:asnd="http://ascendispharma.com/20190630"
  xmlns:srt-types="http://fasb.org/srt-types/2018-01-31"
  xmlns:srt="http://fasb.org/srt/2018-01-31"
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2018-03-16/ifrs-full"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:country="http://xbrl.sec.gov/country/2017-01-31"
  xmlns:currency="http://xbrl.sec.gov/currency/2017-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:exch="http://xbrl.sec.gov/exch/2018-01-31"
  xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31"
  xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31"
  xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31"
  targetNamespace="http://ascendispharma.com/20190630"
  elementFormDefault="qualified" attributeFormDefault="unqualified">
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/DocumentandEntityInformation" id="DocumentandEntityInformation">
        <link:definition>101 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/StatementOfComprehensiveIncomeProfitOrLossByFunctionOfExpense-310000" id="ias_1_2018-03-16_role-310000">
        <link:definition>103 - Statement - Condensed Consolidated Interim Statements of Profit or Loss and Other Comprehensive Income / (Loss)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/StatementOfComprehensiveIncomeProfitOrLossByFunctionOfExpense-310000Parenthetical" id="ias_1_2018-03-16_role-310000Paren">
        <link:definition>104 - Statement - Condensed Consolidated Interim Statements of Profit or Loss and Other Comprehensive Income / (Loss) (Parenthetical)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/StatementOfFinancialPositionCurrentNonCurrent-210000" id="ias_1_2018-03-16_role-210000">
        <link:definition>105 - Statement - Condensed Consolidated Interim Statements of Financial Position</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/StatementOfChangesInEquity-610000" id="ias_1_2018-03-16_role-610000">
        <link:definition>106 - Statement - Condensed Consolidated Interim Statements of Changes in Equity</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/StatementOfCashFlowsIndirectMethod-520000" id="ias_7_2018-03-16_role-520000">
        <link:definition>107 - Statement - Condensed Consolidated Interim Cash Flow Statements</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" id="Role_NotesToFinancialStatementsDisclosureOfGeneralInformationAboutFinancialStatementsExplanatory">
        <link:definition>108 - Disclosure - General Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" id="Role_NotesToFinancialStatementsDisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory">
        <link:definition>109 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfAccountingJudgementsAndEstimatesExplanatory" id="Role_NotesToFinancialStatementsDisclosureOfAccountingJudgementsAndEstimatesExplanatory">
        <link:definition>110 - Disclosure - Critical Accounting Judgments and Key Sources of Estimation Uncertainty</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfRevenueExplanatory" id="Role_NotesToFinancialStatementsDisclosureOfRevenueExplanatory">
        <link:definition>111 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfEntitysReportableSegmentsExplanatory" id="Role_NotesToFinancialStatementsDisclosureOfEntitysReportableSegmentsExplanatory">
        <link:definition>112 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfEmployeeBenefitsExplanatory" id="Role_NotesToFinancialStatementsDisclosureOfEmployeeBenefitsExplanatory">
        <link:definition>113 - Disclosure - Warrants and Share-based Payment</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfLeasesExplanatory" id="Role_NotesToFinancialStatementsDisclosureOfLeasesExplanatory">
        <link:definition>114 - Disclosure - Leases</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" id="Role_NotesToFinancialStatementsDisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory">
        <link:definition>115 - Disclosure - Share Capital</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfEventsAfterReportingPeriodExplanatory" id="Role_NotesToFinancialStatementsDisclosureOfEventsAfterReportingPeriodExplanatory">
        <link:definition>116 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfSummaryOfSignificantAccountingPoliciesExplanatoryPolicies" id="Role_NotesToFinancialStatementsDisclosureOfSummaryOfSignificantAccountingPoliciesExplanatoryPolicies">
        <link:definition>117 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfSummaryOfSignificantAccountingPoliciesExplanatoryTables" id="Role_NotesToFinancialStatementsDisclosureOfSummaryOfSignificantAccountingPoliciesExplanatoryTables">
        <link:definition>118 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfRevenueExplanatoryTables" id="Role_NotesToFinancialStatementsDisclosureOfRevenueExplanatoryTables">
        <link:definition>119 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfEmployeeBenefitsExplanatoryTables" id="Role_NotesToFinancialStatementsDisclosureOfEmployeeBenefitsExplanatoryTables">
        <link:definition>120 - Disclosure - Warrants and Share-based Payment (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfLeasesExplanatoryTables" id="Role_NotesToFinancialStatementsDisclosureOfLeasesExplanatoryTables">
        <link:definition>121 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation" id="DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation">
        <link:definition>122 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfLeaseLiabilitiesRecognizedInUnauditedCondensedConsolidatedInterimFinancialPosition" id="DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfLeaseLiabilitiesRecognizedInUnauditedCondensedConsolidatedInterimFinancialPosition">
        <link:definition>123 - Disclosure - Summary of Significant Accounting Policies - Summary of Lease Liabilities Recognized in Unaudited Condensed Consolidated Interim Financial Position (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/DisclosureCriticalAccountingJudgmentsAndKeySourcesOfEstimationUncertaintyAdditionalInformation" id="DisclosureCriticalAccountingJudgmentsAndKeySourcesOfEstimationUncertaintyAdditionalInformation">
        <link:definition>124 - Disclosure - Critical Accounting Judgments and Key Sources of Estimation Uncertainty - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/DisclosureRevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLoss" id="DisclosureRevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLoss">
        <link:definition>125 - Disclosure - Revenue - Schedule of Revenue Recognized in Statements of Profit or Loss (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/DisclosureRevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossParenthetical" id="DisclosureRevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossParenthetical">
        <link:definition>126 - Disclosure - Revenue - Schedule of Revenue Recognized in Statements of Profit or Loss (Parenthetical) (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/DisclosureSegmentInformationAdditionalInformation" id="DisclosureSegmentInformationAdditionalInformation">
        <link:definition>127 - Disclosure - Segment Information - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/DisclosureWarrantsAndSharebasedPaymentWarrantActivityAdditionalInformation" id="DisclosureWarrantsAndSharebasedPaymentWarrantActivityAdditionalInformation">
        <link:definition>128 - Disclosure - Warrants and Share-based Payment - Warrant Activity - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/DisclosureWarrantsAndSharebasedPaymentScheduleOfWarrantActivity" id="DisclosureWarrantsAndSharebasedPaymentScheduleOfWarrantActivity">
        <link:definition>129 - Disclosure - Warrants and Share-based Payment - Schedule of Warrant Activity (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/DisclosureWarrantsAndSharebasedPaymentSummaryOfWarrantCompensationCost" id="DisclosureWarrantsAndSharebasedPaymentSummaryOfWarrantCompensationCost">
        <link:definition>130 - Disclosure - Warrants and Share-based Payment - Summary of Warrant Compensation Cost (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/DisclosureLeasesAdditionalInformation" id="DisclosureLeasesAdditionalInformation">
        <link:definition>131 - Disclosure - Leases - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/DisclosureLeasesSummaryOfMaturityProfileOfLeaseLiabilities" id="DisclosureLeasesSummaryOfMaturityProfileOfLeaseLiabilities">
        <link:definition>132 - Disclosure - Leases - Summary of Maturity Profile of Lease Liabilities (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ascendispharma.com/taxonomy/role/DisclosureShareCapitalAdditionalInformation" id="DisclosureShareCapitalAdditionalInformation">
        <link:definition>133 - Disclosure - Share Capital - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:href="asnd-20190630_cal.xml" xlink:title="Calculation Links, all"/>
      <link:linkbaseRef xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:href="asnd-20190630_def.xml" xlink:title="Definition Links, all"/>
      <link:linkbaseRef xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:href="asnd-20190630_lab.xml" xlink:title="Label Links, all"/>
      <link:linkbaseRef xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:href="asnd-20190630_pre.xml" xlink:title="Presentation Links, all"/>
    </appinfo>
  </annotation>
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <import namespace="http://fasb.org/srt-types/2018-01-31" schemaLocation="http://xbrl.fasb.org/srt/2018/elts/srt-types-2018-01-31.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <import namespace="http://fasb.org/srt/2018-01-31" schemaLocation="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd"/>
  <import namespace="http://xbrl.ifrs.org/taxonomy/2018-03-16/ifrs-full" schemaLocation="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd"/>
  <import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/currency/2017-01-31" schemaLocation="https://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/exch/2018-01-31" schemaLocation="https://xbrl.sec.gov/exch/2018/exch-2018-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="https://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="https://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd"/>
  <element name="AdjustmentsForIncreaseDecreaseInOperatingLeaseDeposits" id="asnd_AdjustmentsForIncreaseDecreaseInOperatingLeaseDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="AdjustmentsForIncreaseDecreaseInPrepayments" id="asnd_AdjustmentsForIncreaseDecreaseInPrepayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="AggregateNumberOfOtherEquityInstrumentsCancelledInSharebasedPaymentArrangement" id="asnd_AggregateNumberOfOtherEquityInstrumentsCancelledInSharebasedPaymentArrangement" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ChangesInWorkingCapitalAbstract" id="asnd_ChangesInWorkingCapitalAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ContractualUndiscountedCashflowOfFinancialLiabilities" id="asnd_ContractualUndiscountedCashflowOfFinancialLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="CostsOfCapitalIncreaseDecrease" id="asnd_CostsOfCapitalIncreaseDecrease" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DeferredRevenueFromAssociate" id="asnd_DeferredRevenueFromAssociate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DisclosureOfEmployeeCompensationCostsAbstract" id="asnd_DisclosureOfEmployeeCompensationCostsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DisclosureOfImpactOfIfrs16ApplicationOnConsolidatedStatementsOfFinancialPositionExplanatory" id="asnd_DisclosureOfImpactOfIfrs16ApplicationOnConsolidatedStatementsOfFinancialPositionExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DisclosureOfSegmentRevenuesByDestinationOfMajorCustomersExplanatory" id="asnd_DisclosureOfSegmentRevenuesByDestinationOfMajorCustomersExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DisclosureOfSummaryOfSignificantAccountingPoliciesAbstract" id="asnd_DisclosureOfSummaryOfSignificantAccountingPoliciesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DisclosureOfWarrantActivityLineItems" id="asnd_DisclosureOfWarrantActivityLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DisclosureOfWarrantCompensationsCostExplanatory" id="asnd_DisclosureOfWarrantCompensationsCostExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DistributableEquity" id="asnd_DistributableEquity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DocumentAndEntityInformationAbstract" id="asnd_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="EuroMember" id="asnd_EuroMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="GeneralAndAdministrativeExpenseMember" id="asnd_GeneralAndAdministrativeExpenseMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="GeneralAndAdministrativeExpensesMember" id="asnd_GeneralAndAdministrativeExpensesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="IncomeStatementLocation1Member" id="asnd_IncomeStatementLocation1Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="IncomeStatementLocationAxis" id="asnd_IncomeStatementLocationAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem"/>
  <element name="LeaseExtensionPeriod" id="asnd_LeaseExtensionPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NoncashConsideration" id="asnd_NoncashConsideration" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NonCurrentAssetsFinanceLiabilitiesAbstract" id="asnd_NonCurrentAssetsFinanceLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NumberOfInstrumentsAuthorisedInSharebasedPaymentArrangement" id="asnd_NumberOfInstrumentsAuthorisedInSharebasedPaymentArrangement" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NumberOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" id="asnd_NumberOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NumberOfReportableOperatingSegments" id="asnd_NumberOfReportableOperatingSegments" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NumberOfSharesIssuedPublicOffering" id="asnd_NumberOfSharesIssuedPublicOffering" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="PercentageBorrowingsDenominatedInFixedRate" id="asnd_PercentageBorrowingsDenominatedInFixedRate" type="num:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ResearchAndDevelopmentCostMember" id="asnd_ResearchAndDevelopmentCostMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ResearchAndDevelopmentCostsMember" id="asnd_ResearchAndDevelopmentCostsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ShortTermContractsAndLowValueAssets" id="asnd_ShortTermContractsAndLowValueAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="StatementLineItems" id="asnd_StatementLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="StatementOfComprehensiveIncomeProfitOrLossLocationAxis" id="asnd_StatementOfComprehensiveIncomeProfitOrLossLocationAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem"/>
  <element name="StatementOfComprehensiveIncomeProfitOrLossLocationMember" id="asnd_StatementOfComprehensiveIncomeProfitOrLossLocationMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="StatementTable" id="asnd_StatementTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem"/>
  <element name="TextBlockAbstract" id="asnd_TextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="UndiscountedOperatingLeaseObligation" id="asnd_UndiscountedOperatingLeaseObligation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="USDollarMember" id="asnd_USDollarMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="Warrant1Member" id="asnd_Warrant1Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="WeightedAverageExercisePriceOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" id="asnd_WeightedAverageExercisePriceOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
</schema>
